| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.4 | 0.02 |